ResearcherTechnische Universität DresdenNo recent work listed
Ioana Plesca
Matched on OpenAlex author ID A5112878234. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2021: 1 paper · 2022: 2 papers · 2023: 1 paper
Papers 4
- VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. Co-author DOI 10.3390/cancers15082326↗
- Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. First author DOI 10.1172/jci.insight.152761↗
- Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14051216↗
- LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer. First author DOI 10.3390/cancers13061297↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Adrian M. Seifert · 4 shared papers, 2021–2023 · strength 0.54
- Paper VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. DOI 10.3390/cancers15082326↗
- Paper Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. DOI 10.1172/jci.insight.152761↗
- Paper Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocar… DOI 10.3390/cancers14051216↗
- Max Heiduk · 4 shared papers, 2021–2023 · strength 0.54
- Paper VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. DOI 10.3390/cancers15082326↗
- Paper Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. DOI 10.1172/jci.insight.152761↗
- Paper Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocar… DOI 10.3390/cancers14051216↗
- Marc Schmitz · 4 shared papers, 2021–2023 · strength 0.54
- Paper VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. DOI 10.3390/cancers15082326↗
- Paper Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. DOI 10.1172/jci.insight.152761↗
- Paper Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocar… DOI 10.3390/cancers14051216↗
- Lena Seifert · 4 shared papers, 2021–2023 · strength 0.54
- Paper VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. DOI 10.3390/cancers15082326↗
- Paper Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. DOI 10.1172/jci.insight.152761↗
- Paper Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocar… DOI 10.3390/cancers14051216↗
- Jürgen Weitz · 4 shared papers, 2021–2023 · strength 0.54
- Paper VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. DOI 10.3390/cancers15082326↗
- Paper Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. DOI 10.1172/jci.insight.152761↗
- Paper Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocar… DOI 10.3390/cancers14051216↗
- David Digomann · 3 shared papers, 2021–2023 · strength 0.41
- Paper VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. DOI 10.3390/cancers15082326↗
- Paper Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. DOI 10.1172/jci.insight.152761↗
- Paper LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer. DOI 10.3390/cancers13061297↗
- Luise Rupp · 1 shared paper, 2023 · strength 0.16
- Marius Distler · 1 shared paper, 2023 · strength 0.16
- Christoph Kahlert · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.